U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H20O8
Molecular Weight 400.3787
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4'-DEMETHYLEPIPODOPHYLLOTOXIN

SMILES

[H][C@]12COC(=O)[C@]1([H])[C@H](C3=CC(OC)=C(O)C(OC)=C3)C4=C(C=C5OCOC5=C4)[C@H]2O

InChI

InChIKey=YVCVYCSAAZQOJI-JHQYFNNDSA-N
InChI=1S/C21H20O8/c1-25-15-3-9(4-16(26-2)20(15)23)17-10-5-13-14(29-8-28-13)6-11(10)19(22)12-7-27-21(24)18(12)17/h3-6,12,17-19,22-23H,7-8H2,1-2H3/t12-,17+,18-,19+/m0/s1

HIDE SMILES / InChI
4'-demethylepipodophyllotoxin (DMEP) belongs to the class of podophyllotoxin. Podophyllotoxin is a natural product from the roots and rhizomes of Podophyllum species and binds at the colchicine site as a microtubule inhibitor. DMEP is an antimitotic agent which binds to monomeric tubulin, preventing microtubule polymerization. It can reduce the tumor formation and growth in a mouse skin carcinogenesis model. DMEP derivatives exert strong antitumor properties.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Structure of 4'-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design.
2017 Nov 4
Patents

Sample Use Guides

The backs of the animals were shaved 2 days prior to the start of the experiment. The animals were divided into three groups (n = 10 for each group). Group I animals served as controls. These animals received acetone (200 μl/mouse) application only. Group II animals received two topical applications of 0.24% 9, 10-dimethylbenz[a]anthracene (DMBA) in acetone (200 μl/mouse) over a period of 1 week, followed by 5 nmol 12-O-tetradecanoylphorbol-13-acetate (TPA) in acetone (50 μl/mouse) twice weekly for 24 weeks. The mice of group III were treated as Group II mice, except that they were treated with 4'-demethylepipodophyllotoxin (DMEP) (200 μl of the solution in acetone at a concentration of 1 μg/ml), 30 min prior to application of the above dose of TPA twice weekly for 24 weeks.
Route of Administration: Transdermal
In Vitro Use Guide
Curator's Comment: Treatment of Chinese hamster cells with 4'-demethylepipodophyllotoxin caused a dose-dependent increase in the mitotic index. https://www.ncbi.nlm.nih.gov/pubmed/8517914
4'-demethylepipodophyllotoxin (DMEP) showed cytotoxicity activity against five human tumor cell lines (i.e., BGC-823, KB, HepG2, K-562, and HL-60) and a normal human cell line (i.e., HK-2) The EC50s of DMEP against these tumor cell lines ranged from 0.31 to 398 uM.
Name Type Language
4'-DEMETHYLEPIPODOPHYLLOTOXIN
Common Name English
(-)-4'-DEMETHYLEPIPODOPHYLLOTOXIN
Common Name English
TENIPOSIDE RELATED COMPOUND A [USP-RS]
Common Name English
4'-O-DEMETHYLEPIPODOPHYLLOTOXIN
Common Name English
TENIPOSIDE RELATED COMPOUND A [USP IMPURITY]
Common Name English
TENIPOSIDE RELATED COMPOUND A
USP-RS  
Common Name English
FURO(3',4':6,7)NAPHTHO(2,3-D)-1,3-DIOXOL-6(5AH)-ONE, 5,8,8A,9-TETRAHYDRO-9-HYDROXY-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-, (5R,5AR,8AR,9S)-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID7048742
Created by admin on Sat Dec 16 09:53:58 GMT 2023 , Edited by admin on Sat Dec 16 09:53:58 GMT 2023
PRIMARY
FDA UNII
X0S6I23X6L
Created by admin on Sat Dec 16 09:53:58 GMT 2023 , Edited by admin on Sat Dec 16 09:53:58 GMT 2023
PRIMARY
CAS
6559-91-7
Created by admin on Sat Dec 16 09:53:58 GMT 2023 , Edited by admin on Sat Dec 16 09:53:58 GMT 2023
PRIMARY
CHEBI
74422
Created by admin on Sat Dec 16 09:53:58 GMT 2023 , Edited by admin on Sat Dec 16 09:53:58 GMT 2023
PRIMARY
PUBCHEM
122797
Created by admin on Sat Dec 16 09:53:58 GMT 2023 , Edited by admin on Sat Dec 16 09:53:58 GMT 2023
PRIMARY
RS_ITEM_NUM
1643747
Created by admin on Sat Dec 16 09:53:58 GMT 2023 , Edited by admin on Sat Dec 16 09:53:58 GMT 2023
PRIMARY